Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy

BMC Musculoskeletal Disorders

Volumn 16, Issue 1, 2015, Pages

  Martini, Giorgia ^a   Biscaro, Francesca ^a   Boscaro, Elisa ^b   Calabrese, Fiorella ^b   Lunardi, Francesca ^b   Facco, Monica ^b   Agostini, Carlo ^b   Zulian, Francesco ^a   Fadini, Gian Paolo ^b  

^a Paediatric Rheumatology Unit Department of Paediatrics   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Angiogenesis; Cardiovascular; Endothelium; Stem cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; C REACTIVE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; ETANERCEPT; GRANULOCYTE COLONY STIMULATING FACTOR; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHOTREXATE; PLATELET DERIVED GROWTH FACTOR BB; STEROID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PROM1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ARTICLE; CELL POPULATION; CHILD; CIRCULATING PROGENITOR CELL; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOTHELIAL PROGENITOR CELL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; JUVENILE RHEUMATOID ARTHRITIS; MALE; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STEROID THERAPY; SYNOVIUM; VISUAL ANALOG SCALE; ANTAGONISTS AND INHIBITORS; ARTHRITIS, JUVENILE; BLOOD; CASE CONTROL STUDY; CELL COUNT; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

AC133 ANTIGEN; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; ANTIGENS, CD34; ARTHRITIS, JUVENILE; BIOMARKERS; CASE-CONTROL STUDIES; CELL COUNT; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; MALE; MICROSCOPY, CONFOCAL; PEPTIDES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; YOUNG ADULT;

EID: 85043225246     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-015-0555-9     Document Type: Article

References (30)

1. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25(10):1991-4.
2. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138-49.
3. Firestein GS. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J Clin Invest. 1999;103(1):3-4.
4. Sullivan KE. Inflammation in juvenile idiopathic arthritis. Rheum Dis Clin North Am. 2007;33(3):365-88.
5. Scola MP, Imagawa T, Boivin GP, Giannini EH, Glass DN, Hirsch R, et al. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. Arthritis Rheum. 2001;44(4):794-801.
6. de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66(5):589-98.
7. Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 2012;110(4):624-37.
8. Pozzoli O, Vella P, Iaffaldano G, Parente V, Devanna P, Lacovich M, et al. Endothelial fate and angiogenic properties of human CD34+ progenitor cells in zebrafish. Arterioscler Thromb Vasc Biol. 2011;31(7):1589-97.
9. Westerweel PE, Verhaar MC. Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol. 2009;5(6):332-40.
10. van Zonneveld AJ, de Boer HC, van der Veer EP, Rabelink TJ. Inflammation, vascular injury and repair in rheumatoid arthritis. Ann Rheum Dis. 2010;69 Suppl 1:i57-60.
11. Haque S, Alexander MY, Bruce IN. Endothelial progenitor cells: a new player in lupus? Arthritis Res Ther. 2012;14(1):203.
12. Distler JH, Beyer C, Schett G, Luscher TF, Gay S, Distler O. Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases. Arthritis Rheum. 2009;60(11):3168-79.
13. Fadini GP, Tognon S, Rodriguez L, Boscaro E, Baesso I, Avogaro A, et al. Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behcet's disease. Clin Exp Rheumatol. 2009;27(5):814-21.
14. Porta C, Caporali R, Epis O, Ramaioli I, Invernizzi R, Rovati B, et al. Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33(7):721-8.
15. Fadini GP, Albiero M, Seeger F, Poncina N, Menegazzo L, Angelini A, et al. Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. Basic Res Cardiol. 2013;108(1):313.
16. Fadini GP, Albiero M, Boscaro E, Cappellari R, Marescotti M, Poncina N, et al. Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care. 2013;36(4):943-9.
17. Papadaki HA, Kritikos HD, Gemetzi C, Koutala H, Marsh JC, Boumpas DT, et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood. 2002;99(5):1610-9.
18. Ruger B, Giurea A, Wanivenhaus AH, Zehetgruber H, Hollemann D, Yanagida G, et al. Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 2004;50(7):2157-66.
19. Silverman MD, Haas CS, Rad AM, Arbab AS, Koch AE. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum. 2007;56(6):1817-26.
20. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Saemann M, et al. Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Ann Rheum Dis. 2007;66(10):1284-8.
21. Li Calzi S, Neu MB, Shaw LC, Kielczewski JL, Moldovan NI, Grant MB. EPCs and pathological angiogenesis: when good cells go bad. Microvasc Res. 2010;79(3):207-16.
22. Fadini GP, Maruyama S, Ozaki T, Taguchi A, Meigs J, Dimmeler S, et al. Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One. 2010;5(7), e11488.
23. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford). 2001;40(6):640-4.
24. Berenson GS, Wattigney WA, Tracy RE, Newman 3rd WP, Srinivasan SR, Webber LS, et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol. 1992;70(9):851-8.
25. Chen CY, Tsao CH, Ou LS, Yang MH, Kuo ML, Huang JL. Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis. 2002;61(2):167-70.
26. Coulson EJ, Ng WF, Goff I, Foster HE. Cardiovascular risk in juvenile idiopathic arthritis. Rheumatology (Oxford). 2013;52(7):1163-71.
27. Vlahos AP, Theocharis P, Bechlioulis A, Naka KK, Vakalis K, Papamichael ND, et al. Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63(12):1736-44.
28. Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation. 2005;111(9):1184-91.
29. Spinelli FR, Metere A, Barbati C, Pierdominici M, Iannuccelli C, Lucchino B, et al. Effect of Therapeutic Inhibition of TNF on Circulating Endothelial Progenitor Cells in Patients with Rheumatoid Arthritis. Mediators Inflamm. 2013;2013:537539.
30. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, et al. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis. 2009;68(2):163-8.